arrow
M

Masahiro Hatori

Japanese Foundation for Cancer Research
H指数:4
被引数:53

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study

吉西他滨单药治疗转移性胰腺癌疗效的药物基因组学分析:GENESECT研究的亚组分析

2026-06-010
OAAI
Usefulness of pharmacy outpatient clinic follow-up for maintaining relative dose intensity in patients on adjuvant CAPOX chemotherapy for gastric cancer

胃癌辅助CAPOX化疗患者中药房门诊随访对维持相对剂量强度的作用

2026-05-010
PRE
Nudge-based patient education by pharmacists to promote self-care behaviors for preventing and mitigating chemotherapy-induced skin toxicity: rationale, design, and study protocol of the PHARM-NUDGE trial

基于助推的患者教育由药剂师实施,以促进预防和管理化疗诱导皮肤毒性的自我护理行为:PHARM-NUDGE试验的原理、设计和研究方案

2026-02-210
PRE
Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study)
CANCER
IF5.1
2024-04-291
PRE
A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I-
2023-12-060
PRE